Christensenhorn5511

Phonetic analysis showed that carrier inconsistency significantly degraded identification of the manner of articulation, especially for stop consonants and, in one of the rooms, also of voicing. Carrier length and carrier/target uncertainty did not affect adaptation to reverberation for individual phonetic features. The detrimental effects of anechoic and different reverberant carriers on target perception were similar. Conclusions The strength of calibration varies across different phonetic features, as well as across rooms with different levels of reverberation. Even though place of articulation is the feature that is affected by reverberation the most, it is the manner of articulation and, partially, voicing for which room adaptation is observed.

Major progress has occurred in multiple myeloma (MM) treatment in recent years, but this is not seen in low- and middle-income countries.

We retrospectively assessed the efficacy and safety of cyclophosphamide, thalidomide, and dexamethasone (cyclophosphamide 400 mg/m

for 5 days, thalidomide 100 mg once daily, if tolerated, and dexamethasone 40 mg once weekly; in 28-day cycles) in patients with newly diagnosed MM treated at our institution between April 2008 and December 2012. Survival outcomes were estimated by the Kaplan-Meier method.

Fifty-nine patients were found to meet the selection criteria. Median age was 56 years (27-78). Tanespimycin nmr Fifty-nine percent (n = 35) were male. International Staging System three was found in 24%. The median number of treatment cycles was 11 (range 4-12). After a median of 81-month follow-up (range 5-138 months), the overall response rate was 69.5%. The complete response and very good partial response were 5% and 32%, respectively. Median progression-free survival (PFS) was 35 months (95% CI, 18 to 41). The 3-year PFS was 47.4% (95% CI, 34.5 to 59.6) and 5-year PFS was 24.9% (95% CI, 14.4 to 36.9). The median of overall survival (OS) was 81 months (95% CI, 33 to not reached). The 3-year OS was 63.4% (95% CI, 49.2 to 74.6), and 5-year OS was 57.5% (95% CI, 43.2 to 69.4). The most common adverse event was neutropenia (grade 3 and 4, 30.5%). Out of 23 patients eligible for stem-cell transplantation, 10 (43.5%) proceeded with autologous transplantation. Treatment-related deaths occurred in four patients (6.7%).

Cyclophosphamide, thalidomide, and dexamethasone achieves good response rates with tolerable toxicity, especially in patients age 65 years or younger representing a feasible approach for patients with MM in low-income health care settings.

Cyclophosphamide, thalidomide, and dexamethasone achieves good response rates with tolerable toxicity, especially in patients age 65 years or younger representing a feasible approach for patients with MM in low-income health care settings.Purpose The purpose of this study was to investigate the possible effects of smartphone usage in the biomechanical balance system. Method Twenty-five healthy young adults (10 men, 15 women) between the ages of 18 and 25 years without balance problems were included in the study. Sensory organization, adaptation, rhythmic weight shift, and functional limitation tests (unilateral stance, sit to stand, walk across, tandem walk, step quick turn, step up down, forward lunge) have been applied. Results Significant results were obtained in parameters of sensory organization, tandem walk, walk across, and unilateral stance tests (p less then .05). Conclusion The effects of using smartphones on postural control and balance in different circumstances, such as standing and walking, must be comprehensively determined to prevent accident.Purpose The aim of the study was to evaluate the relationship between the Screening Checklist for Auditory Processing in Adults and the performance of older adults on a battery of diagnostic tests for auditory processing. This was done for two versions of the checklist, one answered by older individuals at risk for auditory processing disorder (APD) and the other by the family of the older adults. Method Forty-nine older adults and 34 of their family members were initially tested with the screening checklist, each being tested with the version developed for them. Approximately half of the older adults had normal pure-tone thresholds, while the others had mild-moderate hearing loss above 2 kHz. The older adults were administered tests of auditory separation/closure, auditory integration, temporal resolution, temporal patterning, and auditory memory and sequencing. Results Most of the older adults and their family members reported of the presence of auditory processing difficulties on the screening checklist. On the diagnostic test battery, many of the older adults, irrespective of their high-frequency hearing sensitivity, failed the tests measuring temporal resolution and auditory integration. The sensitivity and specificity of the checklist answered by the older individuals were 69.05% and 71.43%, respectively. On the other hand, for the checklist answered by the family members, it was 77.78% and 33.33%, respectively. The test-retest reliability of the two versions of the checklist was found to be good. Conclusions As the specificity of the checklist answered by the family members was considerably lower than that answered by the older adults, the use of the version for the latter group is recommended. However, the checklist answered by the caregivers could be used to complement information obtained from the older adults at risk for APD when the older adults are unable to give valid responses.Objective The aim of this mini-systematic review was to evaluate the evidence reporting speech, language, and auditory behavioral outcome measures for children with a diagnosis of auditory neuropathy spectrum disorder (ANSD) who received cochlear implants (CIs) prior to 3 years of age. Method A mini-systematic review of the literature supporting evidence-based practices was performed. Two databases were searched utilizing a search strategy derived from the PICO (patient, intervention, comparison, outcome) framework. Peer-reviewed articles published between 2009 and 2019 evaluating children with a diagnosis of ANSD who were implanted prior to 3 years of age with a range of speech, language, and auditory behavioral outcomes were included. Four articles meeting inclusion criteria were critically appraised for reputable research design and risks of bias. Each of the four studies was assigned a level of evidence for effectiveness and quality assessment rating. Results Evidence supports cochlear implantation as an appropriate intervention for children with ANSD.